Joint/Bone Health

 

Oral Glucocorticoids and Fracture Risk in RA

September 21, 2020

Low-dose oral glucocorticoid therapy increases only vertebral fracture risk in rheumatoid arthritis patients, a study shows.

Low Vitamin D May Worsen COVID-19

September 16, 2020

Improving vitamin D status might decrease the risk of developing severe respiratory distress and death in COVID-19 cases, shows an observational study presented September 11 at the American Society for Bone and Mineral Research (ASBMR) which was held virtually this week.

Bisphosphonate Use Associated with Increased Fracture Risk

September 16, 2020

Bisphosphonate use, especially for more than five years, is associated with an increased risk of atypical femoral fractures, but this risk falls considerably after discontinuation, according to a Nationwide Danish an analysis and review presented on September 13 at the American Society for Bone and Mineral Research (ASBMR) annual meeting which was held virtually.

Teriparatide for Bone Formation in Hip Fractures

September 16, 2020

Teriparatide, a recombinant human parathyroid hormone analog [rhPTH(1-34)] approved for women and men with osteoporosis, has been shown to renew bone tissue in patients with femoral neck fractures of the hip, according to research presented at the American Society for Bone and Mineral Research (ASBMR) annual meeting which was held this week.

Q&A: Vitamin D and Bone Mineral Density

September 14, 2020

High-dose vitamin D supplementation compared with standard-dose vitamin D supplementation resulted in a greater loss of volumetric bone mineral density in women but not men, according to study data presented at the American Society for Bone and Mineral Research (ASBMR) annual meeting which is being held virtually.

Q&A: Anabolic Agents for Osteoporosis

September 14, 2020

Three months of treatment with the osteoporosis drug abaloparatide (Tymlos, Radius) has a robust effect on bone formation in postmenopausal women with osteoporosis, according to a study presented on Sept. 12 at the American Society for Bone and Mineral Research (ASBMR) annual meeting which is being held virtually.

How long does a shoulder replacement last?

September 03, 2020

Shoulder replacement surgeries are more common in the United States as a treatment for end-stage degenerative conditions. Researchers writing in the current issue of The Lancet Rheumatology, find that most shoulder replacements last longer than 10 years.

The Public Health Crisis of Bone Health

August 20, 2020

In today's issue of Overdrive, the podcast from Rheumatology Network, we focus on bone health. In the U.S. there are about 54 million women and men, who have low bone density and are at risk of having a fracture. And, despite having access to effective treatments, most people are not being tested or treated---even high-risk patients. It's a major public health concern and a crisis in medicine, says one expert.

Two Osteoporosis Medications Shown to Be Equally Effective

August 17, 2020

Raloxifene is as effective as alendronate at preventing osteoporotic hip fractures in women, shows a new study.

Hip Fracture Risk Increases with Tramadol

March 05, 2020

The use of tramadol in older patients is  associated with a higher risk of hip fracture compared with the use of  codeine or commonly used nonsteroidal anti-inflammatory drugs (NSAIDs), say researchers recently writing in in the Journal of Bone and Mineral Research.